Similar articles

• GnRH agonists as adjuncts for in vitro fertilization.

  Meldrum D. Meldrum D. Obstet Gynecol Surv. 1989 May;44(5):314-6. doi: 10.1097/00006254-198905000-00006. Obstet Gynecol Surv. 1989. PMID: 2498794 No abstract available.
• Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.

  Droesch K, Muasher SJ, Brzyski RG, Jones GS, Simonetti S, Liu HC, Rosenwaks Z. Droesch K, et al. Fertil Steril. 1989 Feb;51(2):292-7. doi: 10.1016/s0015-0282(16)60493-4. Fertil Steril. 1989. PMID: 2492234 Clinical Trial.
• Artificial agonadism and hormone replacement for oocyte donation.

  Meldrum DR, Wisot A, Hamilton F, Gutlay-Yeo AL, Marr B, Huynh D. Meldrum DR, et al. Fertil Steril. 1989 Sep;52(3):509-11. doi: 10.1016/s0015-0282(16)60927-5. Fertil Steril. 1989. PMID: 2506080 No abstract available.
• GnRH agonists and in vitro fertilization.

  Barlow DH. Barlow DH. J Reprod Med. 1998 Mar;43(3 Suppl):245-51. J Reprod Med. 1998. PMID: 9564657 Review.
• Role of gonadotropin releasing hormone agonists in ovulation induction.

  Dodson WC. Dodson WC. J Reprod Med. 1989 Jan;34(1 Suppl):76-80. J Reprod Med. 1989. PMID: 2497247 Review.